Last reviewed · How we verify
theophylline based treatment
At a glance
| Generic name | theophylline based treatment |
|---|---|
| Sponsor | Novartis Pharmaceuticals |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
- Prevention of Cisplatin-induced Nephrotoxicity (PHASE2, PHASE3)
- A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator (PHASE4)
- A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming (NA)
- Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD (NA)
- Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- theophylline based treatment CI brief — competitive landscape report
- theophylline based treatment updates RSS · CI watch RSS
- Novartis Pharmaceuticals portfolio CI